Back to Agenda
Assessment of Impact and Effectiveness of Risk Management and Minimization in the EU and US
Session Chair(s)
Saad Shakir, MD, FFPM, FISPE, FRCP
Pharmacovigilance Physician and Pharmacoepidemiologist, ADROITVIGILANCE, United Kingdom
Impacts of Safety Warning and Risk Evaluation and Mitigation Strategies on Drug Utilization and Clinical Outcome
Learning Objective : Discuss methods used to assess the impact and effectiveness of risk management and minimization methods; Identify the application of some of the tools used to examine the effectiveness of risk management and minimization.
Speaker(s)
Annette Stemhagen, DrPH, PHD, FISPE
Chief Science Officer, UBC, United States
Evaluating Risk Evaluation and Mitigation Strategies Effectiveness Using Existing Tools
Jason C. Hsu
Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Taiwan
Impacts of Safety Warning and Risk Evaluation and Mitigation Strategies on Drug Utilization and Clinical Outcome
Saad Shakir, MD, FFPM, FISPE, FRCP
Pharmacovigilance Physician and Pharmacoepidemiologist, ADROITVIGILANCE, United Kingdom
Monitoring and Studying the Effectiveness of Risk Management and Minimization in the EU
Have an account?